Brasada Capital Management’s ResMed RMD Stock Holding History

Brasada Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.15M	Buy	18,437 +934	+5%	+$233K	0.76%	56
2025 Q4	$4.28M	Buy	17,503 +1,024	+6%	+$262K	0.72%	51
2025 Q3	$4.56M	Buy	16,479 +470	+3%	+$128K	0.77%	47
2025 Q2	$4.11M	Buy	16,009 +298	+2%	+$71.1K	0.7%	51
2025 Q1	$3.21M	Buy	+15,711	New	+$3.67M	0.64%	53
2021 Q1	–	Sell	-6,142	Closed	-$1.31M	–	169
2020 Q4	$1.31M	Buy	6,142 +380	+7%	+$75.8K	0.3%	72
2020 Q3	$988K	Sell	5,762 -205	-3%	-$37.9K	0.25%	75
2020 Q2	$1.15M	Buy	5,967 +582	+11%	+$95.2K	0.32%	71
2020 Q1	$793K	Buy	5,385 +143	+3%	+$22.8K	0.28%	64
2019 Q4	$812K	Sell	5,242 -14	-0.3%	-$2.02K	0.2%	86
2019 Q3	$710K	Buy	5,256 +87	+2%	+$11.4K	0.19%	89
2019 Q2	$640K	Sell	5,169 -517	-9%	-$57.3K	0.17%	100
2019 Q1	$591K	Buy	5,686 +51	+0.9%	+$5.26K	0.18%	94
2018 Q4	$642K	Buy	+5,635	New	+$604K	0.21%	83

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brasada Capital Management's RMD Position: Q1 2026 in Review

Brasada Capital Management increased its ResMed (RMD) stake by 5.3% in Q1 2026, buying an estimated $233K and bringing the position to 18,437 shares worth $4.15M. The position accounts for 0.76% of the portfolio, ranked #56.

Brasada Capital Management first reported a position in RMD in Q4 2018 and has held it in 14 quarters since. The position peaked at $4.56M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Brasada Capital Management held 18,437 shares of ResMed worth $4.15M as of Q1 2026.
Brasada Capital Management bought 934 ResMed shares in Q1 2026, an estimated $233K.
ResMed made up 0.76% of Brasada Capital Management's portfolio in Q1 2026, its #56 holding.
Brasada Capital Management first reported a position in ResMed in Q4 2018 and has held it in 14 quarters since.
Brasada Capital Management's ResMed position peaked at $4.56M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Brasada Capital Management's 13F filing for Q1 2026, filed 15 May 2026.